Stockscreener 앱 받기
0.392
5.95%
0.022
전일 마감가:
$0.37
열려 있는:
$0.385
하루 거래량:
90,260
Relative Volume:
0.17
시가총액:
$15.30M
수익:
-
순이익/손실:
$-117.67M
주가수익비율:
-0.1269
EPS:
-3.09
순현금흐름:
$-101.06M
1주 성능:
+5.89%
1개월 성능:
+5.95%
6개월 성능:
-17.84%
1년 성능:
-87.23%
1일 변동 폭
$0.385
$0.40
1주일 범위
$0.36
$0.40
52주 변동 폭
$0.2195
$3.67
Athira Pharma Inc Stock (ATHA) Company Profile
명칭
Athira Pharma Inc
전화
(425) 620-8501
주소
18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL
ATHA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ATHA
Athira Pharma Inc
|
0.392 | 14.80M | 0 | -117.67M | -101.06M | -3.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Athira Pharma Inc Stock (ATHA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-09-19 | 다운그레이드 | Mizuho | Outperform → Neutral |
| 2024-09-04 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2024-09-04 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-09-04 | 다운그레이드 | Rodman & Renshaw | Buy → Neutral |
| 2024-08-19 | 개시 | Rodman & Renshaw | Buy |
| 2022-10-17 | 업그레이드 | JMP Securities | Mkt Perform → Mkt Outperform |
| 2022-07-07 | 개시 | Mizuho | Buy |
| 2022-06-23 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2022-06-23 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-06-23 | 다운그레이드 | Stifel | Buy → Hold |
| 2022-05-10 | 개시 | BTIG Research | Buy |
| 2022-04-21 | 개시 | Berenberg | Buy |
| 2021-12-15 | 개시 | Goldman | Neutral |
| 2020-10-13 | 개시 | Goldman | Buy |
| 2020-10-13 | 개시 | JMP Securities | Mkt Outperform |
| 2020-10-13 | 개시 | Jefferies | Buy |
| 2020-10-13 | 개시 | Stifel | Buy |
모두보기
Athira Pharma Inc 주식(ATHA)의 최신 뉴스
Can momentum traders help lift Athira Pharma Inc.Free Risk-Adjusted Picks With Exit Strategy - Newser
Will Athira Pharma Inc. rebound enough to break evenPortfolio Positioning Strategy With Timing - Newser
Athira Pharma Inc. stock prediction for this weekAI Screener Based Stock Summary Report - Newser
Can machine learning forecast Athira Pharma Inc. recoveryInstitutional Holding Behavior Pattern Analysis - Newser
What to do if you’re stuck in Athira Pharma Inc.Free Stock Selection With High Accuracy - Newser
Reversal indicators forming on Athira Pharma Inc. stockWeekly Trend Watch with Market Signals - Newser
How to monitor Athira Pharma Inc. with trend dashboardsSmart Safety Strategy With Real Data Analysis - Newser
Using R and stats models for Athira Pharma Inc. forecastingFree Low Risk High Return Opportunities - Newser
Using fundamentals and technicals on Athira Pharma Inc.Low Risk Strategy with Smart Entry Zones - Newser
Is Athira Pharma Inc. building a consolidation baseFree Weekly Setup With 3x Return Potential - Newser
Why Athira Pharma Inc. stock attracts strong analyst attentionFast-Growing Stock Candidates - sisain.net
Analyzing Athira Pharma Inc. with risk reward ratio chartsROI Focused Setup Screener With Exit Markers - Newser
Athira Pharma Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire
Athira (ATHA) Q2 Loss Narrows 74% - The Motley Fool
Athira Pharma Q2 net loss narrows - TradingView
Athira's New ALS Drug ATH-1105 Achieves Critical Safety Milestone in Phase 1 Trial, Strategic Review Continues - Stock Titan
Competitive Positioning of Athira Pharma Inc.: Is It Leading or LaggingEntry Opportunity Screener with Confirmation - Newser
Can technical indicators confirm Athira Pharma Inc.’s reversalWeekly Stock Market Strategy Summary - Newser
Athira Pharma (ATHA) to Release Earnings on Thursday - Defense World
How Athira Pharma Inc. stock performs during market volatilityAI Model Forecasting Reversal and Breakout Zones - Newser
Is Athira Pharma Inc. a growth stock or a value stockOver 200% growth - Jammu Links News
Should I hold or sell Athira Pharma Inc. stock in 2025Explosive returns - Jammu Links News
What are analysts’ price targets for Athira Pharma Inc. in the next 12 monthsAchieve rapid returns with smart investment plans - Jammu Links News
Athira Pharma Inc. Stock Analysis and ForecastCapitalize on momentum-driven opportunities - Jammu Links News
What markets is PYPD expanding into Is Athira Pharma Inc. stock a good long term investment optionAchieve breakthrough profits with smart strategies - Jammu Links News
What makes Athira Pharma Inc. stock price move sharplyUnlock steady growth with low-risk stocks - Jammu Links News
Will Athira Pharma Inc. bounce back from current supportTechnical Chart Summary for Momentum Stocks - Newser
Does Athira Pharma Inc. stock perform well during market downturnsCapitalize on fast-moving stock trends - Jammu Links News
What is Athira Pharma Inc. company’s growth strategyExceptional ROI - Jammu Links News
What are the latest earnings results for Athira Pharma Inc.Discover stocks with massive upside potential - Jammu Links News
What institutional investors are buying Athira Pharma Inc. stockGet expert analysis on top stock picks - Jammu Links News
Why is Athira Pharma Inc. stock attracting strong analyst attentionUnlock powerful market insights for success - Jammu Links News
Is it the right time to buy Athira Pharma Inc. stockInvest like a pro with expert recommendations - jammulinksnews.com
How volatile is Athira Pharma Inc. stock compared to the marketMaximize returns with disciplined trading - Jammu Links News
New Product Launches: Will They Boost Athira Pharma Inc. Stock in 2025Daily Trade Setup Forecast with Confidence - Newser
Athira Pharma Inc (ATHA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):